These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37196041)

  • 1. Deficiency of Tregs in hypertension-associated left ventricular hypertrophy.
    Tang Y; Shen L; Bao JH; Xu DY
    J Clin Hypertens (Greenwich); 2023 Jun; 25(6):562-572. PubMed ID: 37196041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum transforming growth factor β
    Liu Y; Lin Y; Huang X; Li Y; Liu Y; Shi L
    Eur J Pediatr; 2023 Dec; 182(12):5439-5446. PubMed ID: 37755472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of irbesartan on phenotypic alterations in monocytes and the inflammatory status of hypertensive patients with left ventricular hypertrophy.
    Zhang J; Yang L; Ding Y
    BMC Cardiovasc Disord; 2021 Apr; 21(1):194. PubMed ID: 33879070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of soluble ST2 in patients with essential hypertension and its relationship with left ventricular hypertrophy.
    Wei P; Liu L; Wang X; Zong B; Liu X; Zhang M; Fu Q; Wang L; Cao B
    ESC Heart Fail; 2023 Feb; 10(1):303-310. PubMed ID: 36210061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy.
    Gabrielli L; Winter JL; Godoy I; McNab P; Padilla I; Cordova S; Rigotti P; Novoa U; Mora I; García L; Ocaranza MP; Jalil JE
    Am J Hypertens; 2014 Jun; 27(6):838-45. PubMed ID: 24363278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 -634C>G polymorphism in hypertensive patients with and without left ventricular hypertrophy.
    Chen F; Guo J; Gao SP; Chen C; Guo YF; Gui L; Geng HH; Ge LJ; Zhu JH; Pan M
    Mol Med Rep; 2011; 4(2):283-9. PubMed ID: 21468565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
    Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
    Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of losartan on left ventricular hypertrophy and plasma transforming growth factor-beta1 in elderly patients with hypertension].
    Wu ZL; Xu DL; Li Y; Lai WY; Huang P; Bai SC; Su L
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):531-3. PubMed ID: 19304546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between circulating concentration of Ang II, ADM and ADT and left ventricular hypertrophy in hypertension.
    Cui Y; Zhu Z; Qi X; Li H; Wu Y; Chen W; Liu Y
    Am J Transl Res; 2019; 11(5):3167-3175. PubMed ID: 31217886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between growth differentiation factor 15 and left ventricular hypertrophy in hypertensive patients and healthy adults.
    Kou H; Jin X; Gao D; Ma R; Dong X; Wei J; Wang X
    Clin Exp Hypertens; 2018; 40(1):8-15. PubMed ID: 29035099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between plasma microRNA-29a and left ventricular hypertrophy in patients with hypertension].
    Yao SY; Liu J; Li Y; Wang M; Wang C; Xue H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Mar; 47(3):215-220. PubMed ID: 30897881
    [No Abstract]   [Full Text] [Related]  

  • 13. The potential prognostic value of ultrasonic characterization (videodensitometry) of myocardial tissue in essential arterial hypertension.
    Di Bello V; Pedrinelli R; Giorgi D; Bertini A; Talini E; Caputo MT; Dell'Omo G; Cioppi A; Moretti L; Paterni M; Giusti C
    Coron Artery Dis; 2000 Oct; 11(7):513-21. PubMed ID: 11023238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships of Blood Pressure Circadian Rhythm and Brain Natriuretic Peptide with Left Ventricular Hypertrophy in the Patients with Primary Hypertension.
    Kou HJ; Wang X; Gao DF; Dong X; Wei J; Ma R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):514-521. PubMed ID: 27825406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients.
    Su Z; Tian S; Liang W
    Cardiovasc Ther; 2019; 2019():4183781. PubMed ID: 31772610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of phagocytic NADPH oxidase activity with hypertensive heart disease: a role for cardiotrophin-1?
    Moreno MU; San José G; Pejenaute Á; Landecho MF; Díez J; Beloqui Ó; Fortuño A; Zalba G
    Hypertension; 2014 Mar; 63(3):468-74. PubMed ID: 24324051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degree of albuminuria is related to left ventricular hypertrophy in hypertensive diabetics and is associated with abnormal left ventricular filling: a pilot study.
    Salmasi AM; Jepson E; Grenfell A; Kirollos C; Dancy M
    Angiology; 2003; 54(6):671-8. PubMed ID: 14666955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertensive left ventricular hypertrophy: relation to beta-adrenergic receptor kinase-1 (betaARK1) in peripheral lymphocytes.
    Park SJ; Choi DJ; Kim CW
    J Hypertens; 2004 May; 22(5):1025-32. PubMed ID: 15097244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension.
    Robador PA; Moreno MU; Beloqui O; Varo N; Redón J; Fortuño A; Zalba G; Díez J
    J Hypertens; 2010 Nov; 28(11):2219-26. PubMed ID: 20683337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1.
    Parrinello G; Licata A; Colomba D; Di Chiara T; Argano C; Bologna P; Corrao S; Avellone G; Scaglione R; Licata G
    J Hum Hypertens; 2005 Jul; 19(7):543-50. PubMed ID: 15944724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.